BioStem Technologies, Inc. (BSEM)
$3.54-3.80%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $60M
- Avg volume
- 67.8K
- Beta
- 0.26
- P/E (TTM)
- -2.13
- Short % float
- 3.12%
- Days to cover
- 4.5
- SI change
- +0.5%
- 1W
- +10.28%
- 1M
- -7.57%
- 3M
- -13.66%
- YTD
- -9.69%
- vs SPY 1W
- +11.65%
- vs SPY 1M
- -11.30%
- vs SPY 3M
- -16.76%
- vs SPY YTD
- -21.78%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SRRKBUYScholar Rock Holding CorporationRECOVERYQ 24$56.50+2.26%
- RAPPBUYRapport Therapeutics, Inc. Common StockBULLQ 37$48.24+0.82%
- EIKNBUYEikon Therapeutics, Inc. Common StockQ -14$11.39+5.95%
- DRIOSELLDarioHealth Corp.RECOVERYQ -1$7.49+4.46%
- JBIOBUYJade Biosciences, Inc.CRISISQ -27$21.34+0.52%
- SLDBSELLSolid Biosciences Inc.RECOVERYQ -12$9.30+2.20%
- APGEBUYApogee Therapeutics, Inc.BULLQ 60$134.75+0.00%
- OLMASELLOlema Pharmaceuticals, Inc.RECOVERYQ 2$10.69-1.93%
- CADLBUYCandel Therapeutics, Inc.BULLQ 22$13.13+6.32%
- PFSABUYProfusa, Inc. Common StockCRISISQ -28$5.46-27.87%
- NPCESELLNeuroPace, Inc.RECOVERYQ 1$14.03+0.07%
- COGTSELLCogent Biosciences, Inc.BEARQ 14$36.73+4.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 3
- GROWTH
- 68
- GARP
- 11
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-45.7%
REV YoY-27.9%
ROE-74.7%
EPS YoY-207.7%
ROA-58.0%
GROSS113
OP39
NET47
[VALUATION]
P/E TTM-2.13
P/E FWD13.81
SECTOR PE22.60
INDUSTRY PE17.46
P/B2.22
P/FCF-
EV/EBITDA-2.48
EV/EBIT-
PEG-
FCF YIELD-14.69%
BUYBACK0.00%
RISK
INT COV∞
D/E4.43
ALTMAN Z-2.24
CURR RATIO0.98
ND/EBITDA-
BETA0.26
NEGATIVE EARNINGS GROWTH (-207.7%)NET INCOME (TTM) < 0
